Acutus Medical Inc (OTCPK:AFIB)
$ 0.0456 -0.00715 (-13.55%) Market Cap: 1.35 Mil Enterprise Value: 20.08 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Acutus Medical Inc To Discuss Results From RECOVER AF Study Transcript

Apr 21, 2023 / 04:00PM GMT
Release Date Price: $0.789 (+6.62%)
Operator

Thank you for standing by. Welcome to Acutus Medical RECOVER AF study results conference call. (Operator Instructions). Please be advised that today's conference is being recorded. I would now like to hand the conference over to David Roman, Chief Executive Officer. Please go ahead.

David Harrison Roman
Acutus Medical, Inc. - CEO, President & Director

Thank you, Justin. Good afternoon, and thank you to everyone joining us today. I'm very excited to have this opportunity to share additional perspective on the RECOVER AF study results that were published earlier this week online in EP Europace. We are especially privileged to have Professor Tim Betts joining us today who was the principal investigator in this key study.

Professor Betts is a Professor of Cardiology at Oxford University Hospital and has been a long-time investigator and supporter of Acutus Medical throughout our journey to bring innovative solutions to treat the most complex of arrhythmia patients. During today's call, Professor Betts will provide a brief summary of the RECOVER AF

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot